CTRI/2019/08/020503尚未招募4 期
Topical rapamycin in the treatment of facial angiofibroma - FA
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients of facial angiofibroma
排除标准
- •Pregnancy, severe illness
研究者
相似试验
已完成
2 期
Development of topical treatment with rapamycin for skin lesions of tuberous sclerosis complextuberous sclerosis complexJPRN-UMIN000002844Department of Dermatology Graduate School of Medicine, Osaka University21
已完成
1 期
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)Tuberous SclerosisNeurofibromatosesNeurofibromaAngiofibromaNCT01031901The University of Texas Health Science Center, Houston52
进行中（未招募）
不适用
Topical rapamycin to treat fibrofolliculomas in Birt-Hogg-Dubé syndrome.Facial fibrofolliculomas in Birt-Hogg-Dubé syndromeEUCTR2009-012740-17-NLMUMC20
已完成
3 期
Topical rapamycin to treat fibrofolliculomas in Birt-Hogg-Dubé syndromefibrofolliculomashair follicle tumors1008362410040798NL-OMON35713niversiteit Maastricht20
已完成
2 期
Topical Rapamycin to Erase Angiofibromas in TSCAngiofibromasTuberous SclerosisNCT01526356The University of Texas Health Science Center, Houston179